TrialCancer chemotherapy and pharmacology2024

Multicenter randomized phase II study on S-1 and oxaliplatin therapy as an adjuvant after hepatectomy for colorectal liver metastases (YCOG1001).

Mayumi Ozawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.